The role of inflammation in contrast-induced nephropathy

British Journal of Radiology

Volumn 87, Issue 1041, 2014, Pages

  Kwasa, E A ^a   Vinayak, S ^a   Armstrong, R ^a  

^a AGA KHAN UNIVERSITY   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CONTRAST MEDIUM; CREATININE;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DISEASE COURSE; FEMALE; HUMAN; INFLAMMATION; KENYA; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RISK FACTOR; TEACHING HOSPITAL; CHEMICALLY INDUCED; INCIDENCE; KIDNEY DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY; RADIOGRAPHY; STATISTICAL MODEL;

ADULT; AGED; C-REACTIVE PROTEIN; CONTRAST MEDIA; FEMALE; HUMANS; INCIDENCE; INFLAMMATION; KIDNEY DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84907546272     PISSN: 00071285     EISSN: 1748880X     Source Type: Journal    
DOI: 10.1259/bjr.20130738     Document Type: Article

References (32)

1. Thomsen HS, Morcos SK. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) Guidelines. Br J Radiol 2003; 76: 513-18.
2. Feldkamp T, Kribben A. Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention. Minerva Med 2008; 99: 177-96.
3. Barrett BJ, Parfrey PS. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med 2006; 354: 379-86. doi: 10.1056/NEJMcp050801
4. Morcos SK. Contrast media-induced nephrotoxicity-questions and answers. Br J Radiol 1998; 71: 357-65.
5. Solomon R, Barrett B. Follow-up of patients with contrast-induced nephropathy. Kidney Int Suppl 2006; 69: S46-50. doi: 10.1038/sj.ki.5000374
6. Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, et al. Nephrotoxicity of ionic and non-ionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 1995; 47: 254-61.
7. Berg KJ. Nephrotoxicity related to contrast media. Scand J Urol Nephrol 2000; 34: 317-22. doi: 10.1080/003655900750048341
8. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996; 275: 1489-94.
9. Tublin ME, Murphy ME, Tessler FN. Current concepts in contrast media-induced nephropathy. AJR Am J Roentgenol 1998; 171: 933-9. doi: 10.2214/ajr.171.4.9762972
10. El Sayed AA, Haylor JL, El Nahas AM, Salzano S, Morcos SK. Haemodynamic effects of water-soluble contrast media on the isolated perfused rat kidney. Br J Radiol 1991; 64: 435-9.
11. Katzberg RW, Morris TW, Burgener FA, Kamm E, Fischer HW. Renal renin and hemodynamic responses to selective renal artery catheterization and angiography. Invest Radiol 1977; 12: 381-8.
12. Katholi RE, Taylor GJ, McCann WP, Woods WT Jr, Womack KA, McCoy CD, et al. Nephrotoxicity from contrast media: attenuation with theophylline. Radiology 1995; 195: 17-22. doi: 10.1148/radiology.195.1.7892462
13. Deray G, Martinez F, Cacoub P, Baumelou B, Baumelou A, Jacobs C. A role for adenosine, calcium and ischemia in radiocontrastinduced intrarenal vasoconstriction. Am J Nephrol 1990; 10: 316-22.
14. Gleeson TG, Bulugahapitiya S. Contrastinduced nephropathy. AJR Am J Roentgenol 2004; 183: 1673-89. doi: 10.2214/ ajr.183.6.01831673
15. Kolonko A, Kokot F, Wiecek A. Contrastassociated nephropathy-old clinical problem and new therapeutic perspectives. Nephrol Dial Transplant 1998; 13: 803-6.
16. WHO. The global burden of disease: 2004 update. Geneva, Switzerland: Department of Health Statistics and Informatics in the Information, Education and Research Cluster; 2004.
17. Stouthard JM, Levi M, Hack CE, Veenhof CH, Romijn HA, Sauerwein HP, et al. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost 1996; 76: 738-42.
18. Portielje JE, Kruit WH, Eerenberg AJ, Schuler M, Sparreboom A, Lamers CH, et al. Interleukin 12 induces activation of fibrinolysis and coagulation in humans. Br J Haematol 2001; 112: 499-505.
19. Garlanda C, Bottazzi B, Bastone A, Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 2005; 23: 337-66. doi: 10.1146/ annurev.immunol.23.021704.115756
20. Du Clos TW, Mold C. C-reactive protein. An activator of innate immunity and a modulator of adaptive immunity. Immunol Res 2004; 30: 261-77.
21. Cochran ST, Wong WS, Roe DJ. Predicting angiography-induced acute renal function impairment: clinical risk model. AJR Am J Roentgenol 1983; 141: 1027-33. doi: 10.2214/ ajr.141.5.1027
22. Lloyd-Jones DM, Liu K, Tian L, Greenland P. Narrative review: assessment of C-reactive protein in risk prediction for cardiovascular disease. Ann Intern Med 2006; 145: 35-42.
23. Barrett BJ, Katzberg RW, Thomsen HS, Chen N, Sahani D, Soulez G, et al. Contrastinduced nephropathy in patients with chronic kidney disease undergoing computed tomography a double-blind comparison of iodixanol and iopamidol. Invest Radiol 2006; 41: 11-15.
24. Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, et al. Contrast materialinduced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 1989; 320: 143-9. doi: 10.1056/ NEJM198901193200303
25. Mwanzi S. Risk of contrast induced nephropathy in HIV patients receiving radiographic contrast at three Aga Khan Hospitals. MMed dissertation. Nairobi, Kenya: Aga Khan University Hospital, Nairobi; 2009.
26. Schlesselman JJ. Sample size requirements in cohort and case-control studies of disease. Am J Epidemiol 1974; 99: 381-4.
27. Singh J, Daftary A. Iodinated contrast media and their adverse reactions. J Nucl Med Technol 2008; 36: 69-74. doi: 10.2967/ jnmt.107.047621
28. American College of Radiology. ACR manual on contrast media. Version 8. 2012.
29. Soto K, Coelho S, Rodrigues B, Martins H, Frade F, Lopes S, et al. Cystatin C as a marker of acute kidney injury in the emergency department. Clin J Am Soc Nephrol 2010; 5: 1745-54. doi: 10.2215/CJN.00690110
30. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, FahyM, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004; 44: 1393-99.
31. Khan JK, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV, Shimshak TM, et al. High-dose contrast agent administration during complex coronary angioplasty. Am Heart J 1990; 120: 533-6.
32. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors and relationship to mortality. Am J Med 1997; 103: 368-75.